(secondQuint)Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer.

 OBJECTIVES: I.

 Evaluate the feasibility of administering Rosuvastatin to breast cancer patients undergoing treatment with anthracyclines, paclitaxel, cyclophosphamide, and trastuzumab for breast cancer.

 OUTLINE: Patients are randomized to 1 of 2 treatment arms.

 Arm I: Patients receive rosuvastatin orally (PO) once daily for 3 months in the absence of disease progression or unacceptable toxicity.

 Arm II: Patients receive placebo PO once daily for 3 months in the absence of disease progression or unacceptable toxicity.

.

 Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer@highlight

This randomized pilot clinical trial studies rosuvastatin in treating women with cardiovascular complications who are undergoing chemotherapy for breast cancer.

 Rosuvastatin may prevent or lessen cardiovascular complications in patients undergoing chemotherapy for breast cancer